XYREM (SODIUM OXYBATE) ORAL SOLUTION CIII

The registration has been renewed.

Combined Mark

•

XYREM (SODIUM OXYBATE) ORAL SOLUTION CIII

Key Information

Serial Number

76427104

Registration Number

2952351

Status

the Registration Has Been Renewed.

Ownership

Current Owner

Jazz Pharmaceuticals, Inc.

Address

3000 El Camino Real, 2 Palo Alto Square

Palo Alto, CA 94306

Critical Dates

First Use Date

Oct 7, 2002

Filing Date

Jul 2, 2002

Registration Date

May 17, 2005

Mark Descriptions

Goods

Class 5

Pharmaceutical preparations for use in the treatment of sleep disorders

Mark Elements

Text Mark

XYREM (SODIUM OXYBATE) ORAL SOLUTION CIII

Trademark Timeline

Trademark Assignment

Sep 1, 2000

Assigned to ORPHAN MEDICAL, INC.

Filing Date

Jul 2, 2002

First Use

Oct 7, 2002

Publication Date

Dec 31, 2002

Registration Date

May 17, 2005

Trademark Assignment

Mar 14, 2008

Assigned to ORPHAN MEDICAL, LLC

Trademark Assignment

Mar 17, 2008

Assigned to JPI COMMERCIAL, LLC

Trademark Assignment

Feb 25, 2016

Assigned to JAZZ PHARMACEUTICALS, INC.

USPTO Records

No documents found for this trademark.

Never miss important updates for XYREM (SODIUM OXYBATE) ORAL SOLUTION CIII

Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach